CN104744443A — 嘧啶二酮类化合物盐酸盐新晶型及其制备方法
Assigned to Jiangsu Hansoh Pharmaceutical Group Co Ltd · Expires 2015-07-01 · 11y expired
What this patent protects
本发明涉及嘧啶二酮类化合物盐酸盐新晶型及其制备方法。具体而言,本发明公开了如式I所示的5-氯-6-[(2-亚氨基-1-吡咯烷)甲基]-2,4(1H,3H)-嘧啶二酮盐酸盐的新晶型及其制备方法。该晶型在衍射角2θ为(a)11.73°、(b)13.03°、(c)17.33°、(d)17.97°、(e)23.45°、(f)27.23°、(g)29.40°、(h)32.85°处显示X-射线衍射峰,其稳定性及重现性好,适合医药开发应用。
USPTO Abstract
本发明涉及嘧啶二酮类化合物盐酸盐新晶型及其制备方法。具体而言,本发明公开了如式I所示的5-氯-6-[(2-亚氨基-1-吡咯烷)甲基]-2,4(1H,3H)-嘧啶二酮盐酸盐的新晶型及其制备方法。该晶型在衍射角2θ为(a)11.73°、(b)13.03°、(c)17.33°、(d)17.97°、(e)23.45°、(f)27.23°、(g)29.40°、(h)32.85°处显示X-射线衍射峰,其稳定性及重现性好,适合医药开发应用。
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.